Trending stocks and more
November’s trading is in its last hours, with stocks—and a range of other asset classes—on pace for strong monthly gains.
Stocks, international currencies, and bitcoin have all risen, with traders betting the Fed is done lifting interest rates as inflation ebbs. On Thursday, the Fed’s preferred inflation gauge offered the latest sign that pricing pressures are softening.
Tweet on the trending stocks
Marketwatch:
Salesforce (CRM): Shares rose 10% shortly after the opening bell
Tesla (TSLA): Shares down 2.5%
Ford (F): Stock slipped 1.5%
Snowflake (SNOW): Shares rose more than 8%
Robinhood Markets (HOOD): Shares gained 2%
AbbVie (ABBV): Agreed to buy ImmunoGen for $10Billion pic.twitter.com/92XjTqVGsT— The_Journalbiz (@the_journalbiz) November 30, 2023
Factset chart
Salesforce (CRM): The business-software company lifted its full-year expectations for operating profit margins, after a round of cost-cutting efforts. Shares rose about 9% shortly after the opening bell.
Tesla (TSLA): The electric-vehicle giant’s shares ticked down 1.5% in morning trading ahead of an event in Texas, at which Tesla is expected to deliver its first Cybertrucks.
Ford (F): The auto maker issued new financial forecasts, and said strikes had cost it $1.7 billion in lost profit. Ford stock slipped 1.5%.
Snowflake (SNOW): The data-software company’s shares rose more than 8% in morning trading. On Wednesday, the company lifted its full-year outlook for product revenue after sales surged more than expected in its third quarter.
Robinhood Markets (HOOD): Shares gained nearly 1% after news that the online brokerage was pushing into the U.K. market.
AbbVie (ABBV), ImmunoGen (IMGN): AbbVie agreed to buy ImmunoGen for about $10.1 billion in a deal that speeds the biopharmaceutical company’s entry into the commercial market for ovarian cancer.